Nephropathy Clinical Trials in Beijing, Beijing Municipality
16 recruitingBeijing, Beijing Municipality, China
Showing 1–16 of 16 trials
Recruiting
Phase 3
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Immunoglobulin A Nephropathy (IgAN)
Biogen454 enrolled228 locationsNCT06935357
Recruiting
Phase 3
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
Primary Membranous Nephropathy
Biogen180 enrolled91 locationsNCT06962800
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
Primary IgA Nephropathy
Hoffmann-La Roche428 enrolled202 locationsNCT05797610
Recruiting
Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Primary IgA Nephropathy
Novartis Pharmaceuticals540 enrolled161 locationsNCT04557462
Recruiting
Phase 4
Rivaroxaban in Idiopathic Membranous Nephropathy
Idiopathic Membranous Nephropathy
Beijing Friendship Hospital134 enrolled1 locationNCT07404436
Recruiting
Phase 3
Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
IgA Nephropathy (IgAN)
Haisco Pharmaceutical Group Co., Ltd.370 enrolled1 locationNCT07390123
Recruiting
Phase 2
A Phase IIa Clinical Study of RG002C0106 Injection in Subjects With Primary IgA Nephropathy
IgA Nephropathy (IgAN)
Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd.30 enrolled1 locationNCT07305974
Recruiting
Phase 3
Different Immunosuppressive Treatment in iMN
Idiopathic Membranous Nephropathy
Peking Union Medical College Hospital200 enrolled1 locationNCT04745728
Recruiting
Phase 1
Study of YK012 in Primary Membranous Nephropathy
Primary Membranous Nephropathy
Excyte Biopharma Ltd72 enrolled1 locationNCT06982729
Recruiting
Phase 3
A Trial of HRS-5965 Capsule in Primary IgA Nephropathy
Primary IgA Nephropathy
Chengdu Suncadia Medicine Co., Ltd.378 enrolled1 locationNCT07014826
Recruiting
The Intelligent Prevention And Control System And Strategy For The Whole Disease Cycle Of Diabetic Nephropathy
T2DMDiabetic Nephropathy
Chinese PLA General Hospital2,000 enrolled1 locationNCT06843304
Recruiting
TESTING -ON Post-Trial ObservatioNal Cohort Study
Kidney DiseasesIgA NephropathyGlomerulonephritis+1 more
The George Institute366 enrolled58 locationsNCT05434325
Recruiting
Phase 2
Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients with Primary IgAN
IgA Nephropathy (IgAN)
Haisco Pharmaceutical Group Co., Ltd.80 enrolled2 locationsNCT06670352
Recruiting
A Cohort Study on the Efficacy of Bariatric Surgery for Rapidly Progressing Diabetic Nephropathy
Diabetic NephropathyBariatric Surgeries
China-Japan Friendship Hospital100 enrolled1 locationNCT06661174
Recruiting
Phase 2
Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy
IgA Nephropathy
Keymed Biosciences Co.Ltd70 enrolled1 locationNCT05775042
Recruiting
Phase 4
Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy
NephropathyGlomerular DiseasesIdiopathic Membranous Nephropathy
Chinese PLA General Hospital480 enrolled1 locationNCT05839314